跳至主要内容
临床试验/NL-OMON34645
NL-OMON34645已完成3 期

Dopamine-serotonin dysbalance and the relation to myoclonus and psychiatric co-morbidity in patients with dystonia - Dopamine-serotonin dysbalance in dystonia

Academisch Medisch Centrum0 个研究点目标入组 83 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
83

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age between 35 and 80 years old
  • Primary generalized, segmental or focal dystonia with or without jerks
  • Informed consent
  • Botulinum toxin injections in the Academic Medical Center
  • Stable Tsui scale for severity of dystonia for at least one year

排除标准

  • Other neurological conditions at inclusion or in the past
  • Treatment with deep brain stimulation for dystonia
  • SSRI use in the past 6 months prior to or during the study
  • Use of other anti-depressants during the study, especially MAO-B inhibitors
  • Symptomatic therapy for dystonia other than botulinum toxin, e.g. baclofen or other muscle relaxants.
  • Use of medication with a known effect on dopamine or serotonin receptors or transporters or with a known interaction with escitalopram (e.g. L-DOPA, dopamine-agonists, ritalin, NSAID*s, aspirin, tryptophan, carbamazepine, etcetera)
  • Pregnancy or nursing

研究者

相似试验